Endo (NDOI) Price-to-Free-Cash-Flow : (As of Dec. 14, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Endo Price-to-Free-Cash-Flow?

As of today (2024-12-14), Endo's share price is $24.00. Endo does not have enough years/quarters to calculate the Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024. Therefore GuruFocus does not calculate Price-to-Free-Cash-Flow Ratio at this moment.

The historical rank and industry rank for Endo's Price-to-Free-Cash-Flow or its related term are showing as below:

NDOI's Price-to-Free-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 25.82
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Endo's Free Cash Flow per Share for the three months ended in Sep. 2024 was $0.00.

Endo Price-to-Free-Cash-Flow Historical Data

The historical data trend for Endo's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Price-to-Free-Cash-Flow Chart

Endo Annual Data

Trend

Price-to-Free-Cash-Flow

Endo Quarterly Data
	Jun23	Sep23	Apr24	Sep24
Price-to-Free-Cash-Flow	-	-	-	-

Competitive Comparison of Endo's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Endo's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Endo's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Endo's Price-to-Free-Cash-Flow falls into.

Endo Price-to-Free-Cash-Flow Calculation

Endo's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio	=	Share Price	/	Free Cash Flow per Share (TTM)
	=	24.00	/
	=

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio

Market Cap

Free Cash Flow

Endo (OTCPK:NDOI) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Endo Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Endo's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Price-to-Free-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

1400 Atwater Drive, Malvern, PA, USA, 19355

Website

https://www.endo.com

Endo Inc is a diversified specialty pharmaceutical company that develops, manufactures, markets and sells a broad portfolio of pharmaceutical products across four reportable segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals.